Moderna shares plunge on apparent cancer vaccine data leak
Investing.com -- Moderna shares plunged more than 25% on Thursday, while Merck fell over 3%, after what appeared to be an early release of closely watched clinical trial results for the companies’ experimental cancer vaccine.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo